Security key
249845306
- Security type / class
- Equity / COM NEW
- Total 13F shares
- 37,179
- Total 13F value
- $47,413
- Share change
- +37,179
- SEC-reported price per share
- $1.29
- Number of holders
- 4
- Value change
- +$47,413
- Number of buys
- 4
Report period
Q1 2023
Institutions
4
Top holders
4
DRMA full security history
Ownership snapshot
Full 13F holder table
Dermata Therapeutics, Inc. SEC filings
Dermata Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of DRMA - DERMATA THERAPEUTICS INC - COM NEW (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Proehl Investment Venture...
Disclosed value leader
Proehl Investment Venture...
Comparable rows
0/13
Latest evidence
31 Dec 2022
3/4/5
13F
Highest disclosed value: $6,973,306
13 rows are not safely comparable across share classes.
Showing 1-6 of 13 holder rows.
Quick read
Proehl Investment Ventures LLC has the largest disclosed position value at $6.97M.
0 of 13 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Proehl Investment Ventures LLC's linked filing trail.
Disclosed position value
Top 5
Proehl Investment Ventures LLC
$6.97M
Raymond James Financial Services ...
$58K
Thomas Insley
$34.4K
UBS Group AG
$15.3K
GEODE CAPITAL MANAGEMENT, LLC
$10K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 13 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Proehl Investment Ventures LLC |
3/4/5
10%+ Owner
|
—
mixed-class rows
|
$6,973,306
2,933,531 shares
mixed-class rows
|
— | 17 Aug 2021 |
| Raymond James Financial Services Advisors, Inc. |
13F
Company
|
—
denominator unverified
|
$57,981
141,763 shares
|
— | 31 Dec 2022 |
| Thomas Insley |
3/4/5
Chief Financial Officer
|
—
denominator unverified
|
$34,409
14,337 shares
|
— | 17 Aug 2021 |
| UBS Group AG |
13F
Company
|
—
denominator unverified
|
$15,296
37,308 shares
|
— | 31 Dec 2022 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$10,000
26,666 shares
|
— | 31 Dec 2022 |
| WELLS FARGO & COMPANY/MN |
13F
Company
|
—
denominator unverified
|
$9,995
24,438 shares
|
— | 31 Dec 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
4
Shares
37,179
Rows available
4
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2023 vs Q1 2023 Across Filers
Q1 2023 holders
4
Q1 2023 holders
4
Holder diff
0
| Investor | Q1 2023 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q1 2023 value | Value change | Value Chg % |
|---|